drugset / Trial / NCT02422940
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is an extension study to evaluate the long-term safety, tolerability, and efficacy of two dose strengths of dalfampridine-ER.
Timeline
- Start
- 2015-04
- Primary completion
- 2017-01
- Completion
- 2017-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dalfampridine | Small molecule | 7.5 mg | Oral |
| Comparator | Dalfampridine | Small molecule | 10 mg | Oral |